| |
| | The Rest of the Story |
 | | The dapoxetine story is different, though, in the way that science, marketing, and reimbursement will converge once the product is on the market. |
 | | That latter point may be diminished somewhat in the case of dapoxetine, since people are more willing to pay out of pocket for something that improves their sex life, as compared to, say, something that treats cancer. |
 | | If Forbes is correct, and dapoxetine results in $500 million in sales in the first year, that potentially means that the insurance industry will have to come up with an extra $500 million dollars next year, that they did not have to pay this year. |
| trots.blogspot.com /2005_05_22_trots_archive.html (2549 words) |
|